1. Home
  2. BTG vs CORT Comparison

BTG vs CORT Comparison

Compare BTG & CORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BTG
  • CORT
  • Stock Information
  • Founded
  • BTG 2006
  • CORT 1998
  • Country
  • BTG Canada
  • CORT United States
  • Employees
  • BTG N/A
  • CORT N/A
  • Industry
  • BTG Precious Metals
  • CORT Biotechnology: Pharmaceutical Preparations
  • Sector
  • BTG Basic Materials
  • CORT Health Care
  • Exchange
  • BTG Nasdaq
  • CORT Nasdaq
  • Market Cap
  • BTG 7.5B
  • CORT 7.6B
  • IPO Year
  • BTG N/A
  • CORT N/A
  • Fundamental
  • Price
  • BTG $5.19
  • CORT $72.56
  • Analyst Decision
  • BTG Buy
  • CORT Strong Buy
  • Analyst Count
  • BTG 2
  • CORT 4
  • Target Price
  • BTG $6.25
  • CORT $139.00
  • AVG Volume (30 Days)
  • BTG 54.1M
  • CORT 953.9K
  • Earning Date
  • BTG 11-05-2025
  • CORT 10-29-2025
  • Dividend Yield
  • BTG 1.92%
  • CORT N/A
  • EPS Growth
  • BTG N/A
  • CORT N/A
  • EPS
  • BTG N/A
  • CORT 1.11
  • Revenue
  • BTG $2,172,330,000.00
  • CORT $716,080,000.00
  • Revenue This Year
  • BTG $69.35
  • CORT $30.77
  • Revenue Next Year
  • BTG $8.13
  • CORT $37.75
  • P/E Ratio
  • BTG N/A
  • CORT $65.07
  • Revenue Growth
  • BTG 11.75
  • CORT 25.71
  • 52 Week Low
  • BTG $2.20
  • CORT $42.01
  • 52 Week High
  • BTG $5.94
  • CORT $117.33
  • Technical
  • Relative Strength Index (RSI)
  • BTG 52.53
  • CORT 38.93
  • Support Level
  • BTG $4.91
  • CORT $71.66
  • Resistance Level
  • BTG $5.33
  • CORT $80.29
  • Average True Range (ATR)
  • BTG 0.24
  • CORT 4.36
  • MACD
  • BTG -0.06
  • CORT -1.32
  • Stochastic Oscillator
  • BTG 27.18
  • CORT 14.51

About BTG B2Gold Corp Common shares (Canada)

B2Gold Corp is an international, low-cost, senior gold mining company. It has three operating open-pit gold mines in Mali, Namibia, and the Philippines and numerous exploration projects across four continents. Other assets include the Gramalote and Kiaka gold projects. The company focuses on acquiring and developing interests in mineral properties with a primary focus on gold deposits as gold production forms all its revenue. There is no dependence on a particular purchaser because the gold is sold into various markets. The company's reportable operating segments include its mining operations and development projects, namely Fekola; Masbate; Otjikoto; the Goose Project, and other mineral properties; and corporate and other.

About CORT Corcept Therapeutics Incorporated

Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. The company's compounds are being evaluated in clinical trials as potential treatments for a variety of serious disorders - hypercortisolism, advanced ovarian cancer, prostate cancer, ALS, and MASH.

Share on Social Networks: